> top > docs > PubMed:26459796 > annotations

PubMed:26459796 JSONTXT

Annnotations TAB JSON ListView MergeView

wangzhuo19_800

Id Subject Object Predicate Lexical cue
T1 10-19 CI denotes patiromer
T2 199-208 CI denotes patiromer
T3 532-541 CI denotes patiromer
T4 909-918 CI denotes patiromer
T5 1497-1506 CI denotes patiromer
T6 1616-1625 CI denotes patiromer
T7 1812-1821 CI denotes patiromer
T8 104-117 DP denotes heart failure
T9 122-144 DP denotes chronic kidney disease
T10 368-390 DP denotes Chronic kidney disease
T11 392-395 DP denotes CKD
T12 1768-1771 DP denotes CKD
T13 1116-1129 DP denotes heart failure
T14 1131-1133 DP denotes HF
T15 1776-1778 DP denotes HF
T16 306-319 DP denotes heart failure
T17 321-323 DP denotes HF

luoyt2021_800_3

Id Subject Object Predicate Lexical cue
T1 10-19 CI denotes patiromer
T10 122-144 DP denotes chronic kidney disease
T11 278-291 DP denotes hyperkalaemic
T12 306-319 DP denotes heart failure
T13 321-323 DP denotes HF
T14 368-390 DP denotes Chronic kidney disease
T15 392-395 DP denotes CKD
T16 1768-1771 DP denotes CKD
T17 73-86 DP denotes hyperkalaemia
T18 148-163 CI denotes RAAS inhibitors
T19 409-456 CI denotes renin-angiotensin-aldosterone system inhibitors
T2 199-208 CI denotes patiromer
T20 458-463 CI denotes RAASi
T21 1911-1924 DP denotes hyperkalaemia
T22 1788-1801 DP denotes hyperkalaemic
T23 1539-1552 DP denotes hyperkalaemia
T24 1776-1778 DP denotes HF
T25 1131-1133 DP denotes HF
T26 1116-1129 DP denotes heart failure
T3 1812-1821 CI denotes patiromer
T4 1616-1625 CI denotes patiromer
T5 1497-1506 CI denotes patiromer
T6 909-918 CI denotes patiromer
T7 532-541 CI denotes patiromer
T8 212-245 CI denotes potassium (K(+) )-binding polymer
T9 104-117 DP denotes heart failure
T27 1884-1891 CI denotes placebo
T28 1598-1605 CI denotes placebo
T29 1475-1482 CI denotes placebo
T30 932-939 CI denotes placebo

Linmchun_800_3

Id Subject Object Predicate Lexical cue
T1 10-19 CI denotes patiromer
T10 392-395 DP denotes CKD
T11 1768-1771 DP denotes CKD
T12 1812-1821 CI denotes patiromer
T14 1475-1482 CI denotes placebo
T15 1598-1605 CI denotes placebo
T16 122-144 DP denotes chronic kidney disease
T17 321-323 DP denotes HF
T18 306-319 DP denotes heart failure
T19 278-291 DP denotes hyperkalaemic
T2 199-208 CI denotes patiromer
T20 1776-1778 DP denotes HF
T21 1788-1801 DP denotes hyperkalaemic
T22 1911-1924 DP denotes hyperkalaemia
T23 104-117 DP denotes heart failure
T24 73-86 DP denotes hyperkalaemia
T25 1539-1552 DP denotes hyperkalaemia
T26 1884-1891 CI denotes placebo
T27 409-456 CI denotes renin-angiotensin-aldosterone system inhibitors
T28 458-463 CI denotes RAASi
T29 212-245 CI denotes potassium (K(+) )-binding polymer
T3 532-541 CI denotes patiromer
T30 148-163 CI denotes RAAS inhibitors
T31 1131-1133 DP denotes HF
T32 1116-1129 DP denotes heart failure
T4 909-918 CI denotes patiromer
T5 932-939 CI denotes placebo
T6 1497-1506 CI denotes patiromer
T7 1616-1625 CI denotes patiromer
T9 368-390 DP denotes Chronic kidney disease